Who Owns AC Immune SA Stock?
NASDAQ: ACIUHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 24.33%
- Held by insiders
- 38.09%
- Institutional holders
- 59
- Institutions 24.3%
- Insiders 38.1%
- Public and other 37.6%
Who owns AC Immune SA stock?
Institutional investors own about 24.3% of AC Immune SA's shares, spread across 59 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 38.09% of ACIU.
The largest institutional holders are BVF Inc. (19.48%), Wells Fargo & Company (0.99%) and Renaissance Technologies, LLC (0.83%). Together, the top 10 institutions control 23.6% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their ACIU positions and 6 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ACIU
| Institution | Shares | % Held | Change |
|---|---|---|---|
| BVF Inc. | 19.82M | 19.48% | 0.0% |
| Wells Fargo & Company | 1.00M | 0.99% | -0.0% |
| Renaissance Technologies, LLC | 840.13K | 0.83% | +34.6% |
| Millennium Management Llc | 773.59K | 0.76% | -2.4% |
| Blackrock Inc. | 519.27K | 0.51% | -0.9% |
| Dimensional Fund Advisors LP | 340.08K | 0.33% | -12.8% |
| Arrowstreet Capital, Limited Partnership | 232.95K | 0.23% | -42.6% |
| Citadel Advisors Llc | 207.61K | 0.20% | -22.3% |
| Morgan Stanley | 131.81K | 0.13% | +47.7% |
| Two Sigma Investments, LP | 102.83K | 0.10% | +163.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ACIU
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Biotechnology ETF | 457.33K | 0.45% |
| Dimensional ETF Trust-Dimensional U.S. Small Cap ETF | 80.74K | 0.08% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 69.85K | 0.07% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Portfolio | 45.39K | 0.04% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Micro Cap Portfolio | 44.07K | 0.04% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Vector Equity Portfolio | 15.82K | 0.02% |
| JNL Series Trust-JNL/DFA U.S. Small Cap Fund | 7.97K | 0.01% |
| Dimensional ETF Trust-Dimensional US Core Equity 2 ETF | 7.86K | 0.01% |
| Invesco Exchange-Traded Fund Trust II-Invesco Nasdaq Biotechnology ETF | 6.29K | 0.01% |
| Dimensional ETF Trust-Dimensional US Core Equity 1 ETF | 5.75K | 0.01% |
Frequently asked questions
Who is the largest shareholder of AC Immune SA?
BVF Inc. is the largest institutional shareholder of ACIU, owning 19.48% of shares outstanding (19.82M shares) as of its latest 13F filing.
What percentage of AC Immune SA is owned by institutions?
Institutions own about 24.3% of ACIU shares and 39.3% of the public float.
How much of AC Immune SA do insiders own?
Insiders, such as officers and directors, own about 38.09% of ACIU shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.